Dave Blake
@blakestah.bsky.social
Med School Professor. Brain Physiology researcher. Biomedical Engineer. Biomedical device work. I stimulate mammalian brains to improve cognition. OMHIWDMB.
The Office of the Clerk indicates the discharge petition has 218 signatures.
clerk.house.gov/DischargePet...
clerk.house.gov/DischargePet...
Discharge Petition No. 9, Bill Number: H.Res. 581, 119th Congress
SPONSOR: Thomas Massie DESCRIPTION: Pursuant to clause 2 of rule XV, I, Thomas Massie, move to discharge the Committee on Rules from the consideration of the resolution entitled, a resolution providi...
clerk.house.gov
November 12, 2025 at 9:37 PM
The Office of the Clerk indicates the discharge petition has 218 signatures.
clerk.house.gov/DischargePet...
clerk.house.gov/DischargePet...
And on top of all that, there is one nation that is throwing everything they have at NHP research, and doing so at a SMALL fraction of the cost of doing the work in the USA.
We are not there yet, but it is inevitable that labs in the USA will not be able to stay competitive in this arena.
3/3
We are not there yet, but it is inevitable that labs in the USA will not be able to stay competitive in this arena.
3/3
November 10, 2025 at 8:12 PM
And on top of all that, there is one nation that is throwing everything they have at NHP research, and doing so at a SMALL fraction of the cost of doing the work in the USA.
We are not there yet, but it is inevitable that labs in the USA will not be able to stay competitive in this arena.
3/3
We are not there yet, but it is inevitable that labs in the USA will not be able to stay competitive in this arena.
3/3
And with the NIH administration, it would not be so far fetched for them to do something terminal, like, for example, withdraw core support from the 7 National Primate centers (more than one of which is already under attack from state/local government). Of course, there used to be more than 7.
2/
2/
November 10, 2025 at 8:12 PM
And with the NIH administration, it would not be so far fetched for them to do something terminal, like, for example, withdraw core support from the 7 National Primate centers (more than one of which is already under attack from state/local government). Of course, there used to be more than 7.
2/
2/
The list of institutions supporting NHP research has been notably shrinking over the last 10 years. Including UCSF, for example!
The costs have skyrocketed.
And NHP grant proposals are getting irrational animal welfare concerns from non-NHP users who are unfamiliar with processes.
1/
The costs have skyrocketed.
And NHP grant proposals are getting irrational animal welfare concerns from non-NHP users who are unfamiliar with processes.
1/
November 10, 2025 at 8:12 PM
The list of institutions supporting NHP research has been notably shrinking over the last 10 years. Including UCSF, for example!
The costs have skyrocketed.
And NHP grant proposals are getting irrational animal welfare concerns from non-NHP users who are unfamiliar with processes.
1/
The costs have skyrocketed.
And NHP grant proposals are getting irrational animal welfare concerns from non-NHP users who are unfamiliar with processes.
1/
The ice is so thin right now....and could so easily be broken irreparably.
November 10, 2025 at 6:29 PM
The ice is so thin right now....and could so easily be broken irreparably.
The term I heard was "least publishable unit", which in the lab in which it wad used was often the acronym LPU.
The LPU was central to that lab's approach.
The LPU was central to that lab's approach.
November 7, 2025 at 10:56 AM
The term I heard was "least publishable unit", which in the lab in which it wad used was often the acronym LPU.
The LPU was central to that lab's approach.
The LPU was central to that lab's approach.
It was a Novo Nordisk executive, representing a company that offers weight loss drugs. His name is Gordon Findlay, and I really hope he feels better!
November 6, 2025 at 9:49 PM
It was a Novo Nordisk executive, representing a company that offers weight loss drugs. His name is Gordon Findlay, and I really hope he feels better!
I had a forward funded grant before 2020. It was ADRD.
NIA was using ADRD forward funding to spend their appropriation. Not enough good proposals.
And in FY25 NIH just marked grants under the normal payline as ADRD, effectively not funding ANY extra grants in dementia research.
NIA was using ADRD forward funding to spend their appropriation. Not enough good proposals.
And in FY25 NIH just marked grants under the normal payline as ADRD, effectively not funding ANY extra grants in dementia research.
November 3, 2025 at 11:02 PM
I had a forward funded grant before 2020. It was ADRD.
NIA was using ADRD forward funding to spend their appropriation. Not enough good proposals.
And in FY25 NIH just marked grants under the normal payline as ADRD, effectively not funding ANY extra grants in dementia research.
NIA was using ADRD forward funding to spend their appropriation. Not enough good proposals.
And in FY25 NIH just marked grants under the normal payline as ADRD, effectively not funding ANY extra grants in dementia research.
I was excited to see you and my former lab tech (DM) in the same session but then I noticed @dbuono.bsky.social was speaking and I feel guilty about holding his brain since 1998...
November 3, 2025 at 7:52 PM
I was excited to see you and my former lab tech (DM) in the same session but then I noticed @dbuono.bsky.social was speaking and I feel guilty about holding his brain since 1998...
FDA approval of translational invasive neuromodulation invariably REQUIRES some large mammal work.
For neurological applications, I don’t think anything other than NHPs will work.
But the future is surely headed to a time when Chinese labs set up with GCP do this testing.
For neurological applications, I don’t think anything other than NHPs will work.
But the future is surely headed to a time when Chinese labs set up with GCP do this testing.
November 3, 2025 at 12:32 PM
FDA approval of translational invasive neuromodulation invariably REQUIRES some large mammal work.
For neurological applications, I don’t think anything other than NHPs will work.
But the future is surely headed to a time when Chinese labs set up with GCP do this testing.
For neurological applications, I don’t think anything other than NHPs will work.
But the future is surely headed to a time when Chinese labs set up with GCP do this testing.
China is strangely absent from the last chart, and they are big spenders.
November 2, 2025 at 12:56 PM
China is strangely absent from the last chart, and they are big spenders.
